logo
  

Remgro Reaches Agreement On Terms Of Acquisition Of Mediclinic

The boards of Manta Bidco, Remgro, SAS and Mediclinic have reached an agreement on the terms of a recommended cash offer to be made by Bidco to acquire the entire issued and to be issued ordinary share capital of Mediclinic, other than the 328,497,888 Mediclinic shares already owned by the relevant Remgro subsidiaries. Manta Bidco is a newly formed company owned by joint offerors: Remgro; and SAS Shipping Agencies Services, a subsidiary of MSC Mediterranean Shipping Company SA. Scheme shareholders shall be entitled to receive 504 pence in cash for each Mediclinic share held.

The deal values the entire issued and to be issued ordinary share capital of Mediclinic at approximately 3.7 billion pounds, and an implied enterprise value of approximately 6.1 billion pounds.

Mediclinic shareholders shall be entitled to receive the final dividend of 3 pence per Mediclinic share declared by Mediclinic on 25 May 2022.

For comments and feedback contact: editorial@rttnews.com

Business News

Follow RTT